Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83)

Toon andere (1) versies

Aims: Evidence of ethnic differences in vascular complications of diabetes has been inconsistent. The aim of this study was to examine the relationship between ethnicity and long-term outcome in a large sample of individuals with newly diagnosed Type 2 diabetes. Methods: In a prospective observation...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Davis, T, Coleman, R, Holman, R
Formaat:	Journal article
Gepubliceerd in:	2014

Gelijkaardige items

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
door: Davis, T, et al.
Gepubliceerd in: (2014)

Ethnic differences in diabetic nephropathy - The UKPDS
door: Stevens, R, et al.
Gepubliceerd in: (1999)

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
door: Davis, T, et al.
Gepubliceerd in: (2013)

UKPDS: what was the question? UK Prospective Diabetes Study.
door: Turner, R, et al.
Gepubliceerd in: (1999)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
door: Clarke, P, et al.
Gepubliceerd in: (2004)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
door: Coleman, R, et al.
Gepubliceerd in: (2005)

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
door: Davis, T, et al.
Gepubliceerd in: (2001)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
door: Matthews, DR, et al.
Gepubliceerd in: (1998)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
door: Davis, T, et al.
Gepubliceerd in: (1999)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
door: Alva, M, et al.
Gepubliceerd in: (2014)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
door: Coleman, R, et al.
Gepubliceerd in: (2006)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
door: Coleman, R, et al.
Gepubliceerd in: (2007)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
door: Holman, R
Gepubliceerd in: (2007)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
door: Stratton, I, et al.
Gepubliceerd in: (2000)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
door: Turner, R, et al.
Gepubliceerd in: (1999)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
door: Kohner, E, et al.
Gepubliceerd in: (2001)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
door: Cull, C, et al.
Gepubliceerd in: (2001)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
door: Turner, R, et al.
Gepubliceerd in: (1991)

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
door: Hayes, A, et al.
Gepubliceerd in: (2013)

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82
door: Hayes, A, et al.
Gepubliceerd in: (2013)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
door: Adler, A, et al.
Gepubliceerd in: (2003)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
door: Leal, J, et al.
Gepubliceerd in: (2021)

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
door: Coleman, RL, et al.
Gepubliceerd in: (2019)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
door: Stevens, R, et al.
Gepubliceerd in: (2002)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
door: Cull, C, et al.
Gepubliceerd in: (2004)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
door: Horton, V, et al.
Gepubliceerd in: (1999)

Risk factors for neuropathy in UKPDS
door: Stratton, I, et al.
Gepubliceerd in: (2004)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
door: Adler, A, et al.
Gepubliceerd in: (2000)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
door: Price, H, et al.
Gepubliceerd in: (2007)

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.
door: Adler, A, et al.
Gepubliceerd in: (2002)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
door: Adler, A, et al.
Gepubliceerd in: (1999)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
door: Kothari, V, et al.
Gepubliceerd in: (2002)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
door: Stratton, I, et al.
Gepubliceerd in: (2006)

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data
door: Coleman, R, et al.
Gepubliceerd in: (2004)

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
door: Clarke, P, et al.
Gepubliceerd in: (2003)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
door: Stevens, R, et al.
Gepubliceerd in: (2004)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
door: Holman, R, et al.
Gepubliceerd in: (2001)

Inaugural Conference: UKPDS Legacy and Precision Therapy for Type 2 Diabetes Mellitus
door: Rury Holman
Gepubliceerd in: (2022-09-01)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
door: Wamil, M, et al.
Gepubliceerd in: (2020)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
door: Widjaja, A, et al.
Gepubliceerd in: (1996)